Try Fund Library Premium
Free with a 30 day trial!
Cdn Corp Fixed Income
|
Close (05-07-2026) |
$19.96 |
|---|---|
| Change |
-$0.02
(-0.10%)
|
| Open | - |
|---|---|
| Day Range | - - - |
| Volume | 0 |
As at March 31, 2026
No data available
Inception Return (April 29, 2026): -
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Benchmark | -1.77% | 0.25% | 0.57% | 0.25% | 2.77% | 5.76% | 5.74% | 3.94% | 2.27% | 3.11% | 2.79% | 3.03% | 2.91% | 3.02% |
| Category Average | -1.65% | 0.15% | 0.15% | -0.04% | 2.52% | 5.31% | 5.21% | 3.39% | 1.63% | 2.79% | 2.28% | 2.42% | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Return % | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | - | - | - | - |
| Benchmark | -0.59% | 0.75% | 0.27% | 0.04% | 0.18% | 1.54% | 0.68% | 0.27% | -0.63% | 0.89% | 1.16% | -1.77% |
-
-
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | - | - | - | - |
| Benchmark | 3.59% | 3.48% | 0.96% | 8.01% | 8.57% | -1.32% | -10.12% | 8.32% | 7.09% | 4.33% |
| Category Average | - | - | - | 7.34% | 7.62% | -1.82% | -10.25% | 7.57% | 6.68% | 4.15% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - |
-
-
| Standard Deviation | - | - | - |
|---|---|---|---|
| Beta | - | - | - |
| Alpha | - | - | - |
| Rsquared | - | - | - |
| Sharpe | - | - | - |
| Sortino | - | - | - |
| Treynor | - | - | - |
| Tax Efficiency | - | - | - |
| Volatility | - | - | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | - | - | - | - |
| Beta | - | - | - | - |
| Alpha | - | - | - | - |
| Rsquared | - | - | - | - |
| Sharpe | - | - | - | - |
| Sortino | - | - | - | - |
| Treynor | - | - | - | - |
| Tax Efficiency | - | - | - | - |
| Start Date | April 29, 2026 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | - |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Monthly |
| Assets ($mil) | - |
| 52 Week High | $20.02 |
| 52 Week Low | $19.86 |
| Annual Dividend | - |
| Annual Yield | - |
| Index | - |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | - |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
To provide regular income by investing, directly or indirectly, in a diversified portfolio of primarily Canadian dollar-denominated investment-grade bonds, laddered across five maturity groupings ranging from one to five years. We will not change the Fund's fundamental investment objectives without the consent of unitholders by a majority of votes cast at a meeting of unitholders.
To achieve its investment objectives, the Fund: intends to invest up to 100% of its NAV in units of mutual funds (including ETFs) (the Underlying Funds ) managed by us or our affiliates; obtains exposure to Canadian dollar-denominated investment grade bonds by primarily investing in an equally weighted portfolio of five Underlying Funds that have remaining maturities of between one and five years ( ladder ). The Fund currently intends to achieve this exposure by investing in units of CIBC Inves
| Portfolio Manager |
CIBC Asset Management Inc. |
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
CIBC Asset Management Inc. |
|---|---|
| Custodian |
- |
| Registrar |
- |
| Distributor |
- |
| MER | - |
|---|---|
| Management Fee | 0.15% |
Try Fund Library Premium
Free with a 30 day trial!